Objectives: To determine the effect of a single dose of methylphenidate on the cognitive performance of patients with traumatic brain injury (TBI), and particularly on working memory and visuospatial attention.
Design: A double-blind placebo-controlled study. The subjects were randomly divided into an experimental group taking methylphenidate and a control group taking a placebo.
Setting: The Department of Rehabilitation Medicine of a university hospital.
Subjects: Eighteen subjects with TBI (16 male and two female) were enrolled.
Interventions: The patients were given 20 mg methylphenidate or a placebo. Cognitive assessments were performed at three times: before the medication as a baseline, 2 h after medication and at follow-up (48 h later).
Main measures: Cognitive assessments consisted of working memory tasks and endogenous visuospatial attention tasks designed using SuperLabPro 2.0 software. Response accuracy and reaction time were measured.
Results: There were significant improvements in response accuracy in the methylphenidate group compared with the placebo group for both the working memory and visuospatial attention tasks. A significant decrease in the reaction time was also observed in the methylphenidate group only for the working memory task.
Conclusions: The administration of single-dose methylphenidate has an effect in improving cognitive functioning following a TBI. The effects were most prominent regarding the reaction time of the working memory.
Get full access to this article
View all access options for this article.
References
1.
1 Bontke CF, Boake C. Principles of brain injury rehabilitation. In Braddom RL ed. Physical medicine and rehabilitation, first edition. Saunders, 1996: 1027-1051.
2.
2 Kaelin DL, Cifu DX, Matthies B. Methylphenidate effect on attention deficit in the acutely brain-injured adult. Am J Phys Med Rehabil1996; 77:6-9.
3.
3 Plenger PM, Dixon CE, Castillo RM et al. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Am J Phys Med Rehabil1996; 77: 536-540.
4.
4 Hornyark JE, Nelson VS, Hurvitz EA. The use of methylphenidate in paediatric traumatic brain injury. Pediatr Rehabil1997; 1:15-17.
5.
5 Meyers CA, Weitzner MA, Valentine AD et al. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol1998; 16: 2522-2527.
6.
6 Whyte J, Vaccaro M, Grieb-Neff P, Hart T. Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. J Head Trauma Rehabil2002; 17: 284-299.
7.
7 Patrick PD, Buck ML, Conaway MR et al. The use of dopamine enhancing medications with children in low response states following brain injury. Brain Inj2003; 17: 497-506.
8.
8 Galynker I, Ieronimo C, Miner C et al. Methylphenidate treatment of negative symptoms in patients with dementia. J Neuropsychiat Clin Neurosci1997; 9: 231-239.
9.
9 Grade C, Redford B, Chrostowski J et al. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Am J Phys Med Rehabil1998; 79: 1047-1050.
10.
10 Sekine Y, Iyo M, Tanaka K et al. Effective adjunctive use of low-dose methylphenidate with mianserin for major depression with silent cerebral infarction: a case report. J Clin Psychopharmacol2001; 20: 584-585.
11.
11 Goldstein LB. Amphetamines and related drugs in motor recovery after stroke. Phys Med Rehabil Clin N Am2003; 14: 125-134.
12.
12 Elliott R, Sahakian BJ, Matthews K et al. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl)1997; 131: 196-206.
13.
13 Kevin SL, Darren RG, Parrish TB et al. Neuroanatomic overlap of working memory and spatial attention networks: a functional MRI comparison within subjects. Neuroimage1999; 10: 695-704.
15 Kim Y-H, Gitelman DR, Nobre AC et al. The large-scale network for spatial attention dispalys multifunctional overlap but differential asymmetry. Neuroimage1999; 9: 269-277.
16.
16 Wax P. Analeptic use in clinical toxicology: a historical appraisal. Clin Toxicol1997; 35:203-209.
17.
17 Gilman AG, Goodman LS, Rall TW, Murad F. Neurohumoral transmission and the central nervous system. In Gilman AG, Goodman LS eds. The pharmacological basis of therapeutics. Macmillan, 1985: 236-259.
18.
18 Johnson ML, Roberts MD, Ross AR. Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil1992; 71: 239-242.
19.
19 Speech TJ, Rao SM, Osmon DC et al.A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj1993; 7: 333-338.
20.
20 Gualtieri CT, Evans RW. Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury. Brain Inj1988; 2: 273-290.
21.
21 McFadyen MP, Brown RE, Carry N. Subchronic methylphenidate administration has no effect on locomotion, emotional behavior, or water maze learning in prepubertal mice. Dev Psychobiol2002; 41: 123-132.
22.
22 Kline AE, Yan HQ, Bao J et al. Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci Lett2000; 280: 163-166.
23.
23 Sawaguchi T, Goldman-Rakic PS. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol1994; 71: 515-528.
24.
24 Mehta M, Owen A, Sahakian B et al. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci2000; 20:1-6.
25.
25 Szobot CM, Ketzer C, Cunha RD et al. The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. Eur J Nucl Med Mol Imaging2003; 30: 423-426.
26.
26 Ilic TV, Korchounov A, Ziemann U. Methylphenidate facilitates and disinhibits the motor cortex in intact humans. Neuroreport2003; 15: 773-776.
27.
27 Lazarus LW, Winemiller DR, Lingaam VR. Efficacy and side effect of methylphenidate for stroke depression. J Clin Psychiatry1992; 53: 447-449.
28.
28 Burke DT, Glenn MB, Vesali F et al. Effects of methylphenidate on heart rate and blood pressure among inpatients with acquired brain injury. Am J Phys Med Rehabil2003; 82: 493-497.
29.
29 Wroblewski BA, Leary JM, Phelan AM et al. Methylphenidate and seizure frequency in brain injured patients with seizure disorders. J Clin Psychiatry1992; 53:86-89.
30.
30 Moore JL, McAuley JW, Long L et al.An evaluation of the effects of methylphenidate on outcomes in adult epilepsy patients. Epilepsy Behav2002; 3:92-95.
